• Header news

JandeBoerlab won the Open Science Use Case Award!


It's our pleasure to announce that jandeboerlab won the USE Case competition

at the Open Science Festival Netherlands 2020 #OSF2020NL.

By cBIT-the Compendium for Biomaterial Transcriptomics-website.

One of the most outstanding comment from the reviewers is:

"A clear description of an open science use case: written from the OS angle, even though it is just about PID's and standards, it is an inspirational story" and  “an interesting use case, focused on bioinformatics data sharing. It would be interesting to have a perspective of lessons learned broadly applicable to other domains as well.”

Due to Covid-19, the award ceremony will be on 2 July 2020, 15.15 - 16.45 PM virtually to share the inspiration offered by this use case with the wider open science community.

Open Science festival will be held on February 11th, 2021.

TUe and BiS Welcome Burcu!


csm thuiswerker burcu1 b619c5c8d7

TUe and BiS Welcome Burcu! Please read her interview especially about working from home in these hectic Corona times! Many of us find a lot of overlapping between our experiences! 

Immune Modulation by Topographies just accepted in Advanced Science!



Our collaborative work conducted in University of Nottingham in the laboratories of Morgan Alexander and Amir Ghaemmaghami with our TopoChip platform just accepted in Advanced Science. Congratulations to all participating authors. The article is about using topography to control human monocyte attachment and macrophage differentiation to induce pro-inflammatory, anti-inflammatory or regulatory immune responses . You can reach the original article here where you will be inspired once again how topographical cues direct cell fate to provide a platform to design ‘immune-instructive’ biomaterials for implantable medical devices to fight against foreign body rejection.




Boosted by Educational Innovation-Applied Cell Biology Bachelor Course at TUe


ACB debatingACB debating 

Nothing inspires more than hands-on experiencing and debating science and yet, theoretical courses are typically focused on knowledge transfer, and designed in a traditional lecture setup.  In the master’s phase it is more common to supply students with hands-on experiences and the opportunity to apply their knowledge. However, to setup a bachelor course in this way is a big challenge, because of the large number of students. Nevertheless to activate and motivate students it is essential to embed hands-on (practical) experiences in a course and create situations where students are challenged to discuss about what they have learned.

With these above motto, Jan and Sultan designed and run the Applied Cell Biology course for the first time in Q2, 2019-2020 at TUe with a very high number of student enrollment (above 100). "Applied Cell Biology Course Design" project is supported by an Educational Innovation Fund-Boost. The course was designed from scratch to promote active learning. A broad range of innovational teaching learning methods including blended learning, challenge-based learning and research-based learning are carefully implemented in the course design. If you are a BME or BMT student and also interested in Biomedical Engineering Challenges we strongly recommend you to enroll the course. 




Lecture on 'Modernizing glaucoma Surgery: The SEAMS and ISEA projects'



BiS and the Platform for Therapeutic Biomaterials Discovery are hosting Prof. dr. Henny Beckers to give a seminar about 'Modernizing glucoma Surgery: The SEAMS and ISEA projects' on Thursday, 30th, January at Ceres 1.26. Henny is an eye surgeon at Maastricht UMC specialized in glaucoma surgery. She can talk contagiously enthusiastic about surgical challenges related to glaucoma shunt devices and bridges the gap between clinical problems to engineering solutions. 






  • BiS-Biointerface Science in Regenerative Medicine
  • TU/e Department of Biomedical Engineering
Eindhoven University of Technology
PO Box 513
5600 MB, Eindhoven
This email address is being protected from spambots. You need JavaScript enabled to view it.
Cookie & Privacy Statement